Development and Optimization of a Novel Lozenge Containing a Metronidazole-Peppermint Oil-Tranexamic Acid Self-Nanoemulsified Delivery System to Be Used after Dental Extraction: In Vitro Evaluation and In Vivo Appraisal
In-depth studies on essential oil-based nanoemulsions (NEs) have centered on a variety of oral health issues. NEs improve the delivery of nonpolar active agents to sites and thereby boost the dissolution and distribution of the agents. Metronidazole-peppermint oil-tranexamic acid self-nanoemulsifyin...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_a9ec7c9371ff41e7a9550a6d7dc9eb4c | ||
042 | |a dc | ||
100 | 1 | 0 | |a Mohammed Alissa |e author |
700 | 1 | 0 | |a Ahmed Hjazi |e author |
700 | 1 | 0 | |a Ghadah S. Abusalim |e author |
700 | 1 | 0 | |a Ghfren S. Aloraini |e author |
700 | 1 | 0 | |a Suad A. Alghamdi |e author |
700 | 1 | 0 | |a Waleed Y. Rizg |e author |
700 | 1 | 0 | |a Khaled M. Hosny |e author |
700 | 1 | 0 | |a Jazia A. Alblowi |e author |
700 | 1 | 0 | |a Hanaa Alkharobi |e author |
245 | 0 | 0 | |a Development and Optimization of a Novel Lozenge Containing a Metronidazole-Peppermint Oil-Tranexamic Acid Self-Nanoemulsified Delivery System to Be Used after Dental Extraction: In Vitro Evaluation and In Vivo Appraisal |
260 | |b MDPI AG, |c 2023-09-01T00:00:00Z. | ||
500 | |a 10.3390/pharmaceutics15092342 | ||
500 | |a 1999-4923 | ||
520 | |a In-depth studies on essential oil-based nanoemulsions (NEs) have centered on a variety of oral health issues. NEs improve the delivery of nonpolar active agents to sites and thereby boost the dissolution and distribution of the agents. Metronidazole-peppermint oil-tranexamic acid self-nanoemulsifying drug delivery systems (MZ-PO-TX-SNEDDS) were created and loaded into novel lozenges to act as antifungal, hemostatic, antimicrobial, and analgesic dosage forms after dental extractions. The design-of-experiments approach was used in creating them. To generate the NEs, different concentrations of MZ-PO (240, 180, and 120 mg), 2% TX (600, 450, and 300 mg), and S<sub>mix1:1</sub> (600, 400, and 200 mg) were used. The ideal formulation had serum levels of 1530 U/mL of interleukin-6, a minimal inhibitory concentration against bacteria of 1.5 µg/mL, a droplet size of 96 nm, and a blood coagulation time of 16.5 min. Moreover, the produced NE offered better MZ release. The adopted design was used to produce the ideal formulation; it contained 240 mg of MZ-PO, 600 mg of 2% TX, and 600 mg of S<sub>mix1:1.</sub> It was incorporated into lozenges with acceptable characteristics and an improved capability for drug release. These lozenges had reasonable coagulation times, IL-6 serum levels, and MIC values. All of these characteristics are desirable for managing symptoms following tooth extractions. Therefore, these lozenges loaded with MZ-PO-TX-SNEDDs might be considered a beneficial paradigm for relieving complications encountered after tooth extractions. | ||
546 | |a EN | ||
690 | |a metronidazole | ||
690 | |a peppermint oil | ||
690 | |a tranexamic acid | ||
690 | |a nanoemulsion | ||
690 | |a hemostatic | ||
690 | |a optimization | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Pharmaceutics, Vol 15, Iss 9, p 2342 (2023) | |
787 | 0 | |n https://www.mdpi.com/1999-4923/15/9/2342 | |
787 | 0 | |n https://doaj.org/toc/1999-4923 | |
856 | 4 | 1 | |u https://doaj.org/article/a9ec7c9371ff41e7a9550a6d7dc9eb4c |z Connect to this object online. |